These findings underscore the pivotal regulatory function of the PI3K/AKT signaling pathway in platelet desialylation, thereby impacting the pathogenesis of ITP through its influence on platelet activation and apoptosis. The gene discussed is AKT1; the disease is autoimmune thrombocytopenic purpura.